483Mar 7, 2023

483 Document: Rentschler Biopharma SE


FDANews 483 Rentschler Biopharma SE Mar 7 2023 top
Wendy G. Tan FDA Investigator Caryn M. McNab FDA Investigator

On Mar 07, 2023, the FDA inspected Rentschler Biopharma SE's Laupheim site. Explore the inspectional observations.